India to Philippines: Gliclazide Export Trade Route

The India to Philippines Gliclazide corridor is one of India's established pharmaceutical export routes, with 318 shipments documented worth a combined $8.3M USD. The route is dominated by STALLION LABORATORIES PVT LTD, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.

Across 27 active suppliers, the average shipment value stands at $26.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with gliclazide's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 26.7%, placing it at rank #2 among India's top gliclazide export destinations globally.

On the import side, key buyers of Indian gliclazide in Philippines include TO THE ORDER OF., BROWN AND BURK PHILIPPINES INC, M/S.I.E.MEDICA INC and 42 others. TO THE ORDER OF. is the single largest importer with 56 shipments valued at $1.1M USD.

India's gliclazide exports to Philippines are driven primarily by a handful of large-scale manufacturers. STALLION LABORATORIES PVT LTD with 85 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 27 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — STALLION LABORATORIES PVT LTD, MICRO LABS LIMITED, PHARMAFABRIKON — together account for 52% of total trade value on this route. The average shipment value of $26.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine: gliclazide modified release tablets bp 60 mg u/c (gliclyde) unit :10x10 tab and pharmaceutical produts for human use gluclazz mr gliclazide 60 mg modified release tablets , suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF. is the largest importer with 56 shipments worth $1.1M USD — representing 14% of all gliclazide imports from India on this route. A total of 45 buyers are active on this corridor.